|
PCSA Processa Pharmaceuticals Inc 1533743 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,265,494.00 |
| Balance Sheet |
|
Current Assets
|
$2,066,352.00 |
|
Assets
|
$2,069,562.00 |
|
Current Liabilities
|
$2,386,903.00 |
|
Liabilities
|
$2,386,903.00 |
|
Equity
|
$-317,341.00 |
|
Shares Out
|
2793386.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,586,580.00 |
|
Investing Cash Flow
|
$-314,000.00 |
| Market Analysis |
Market Cap
|
$6,005,779.90 |
|
Price
|
$2.15 |
|
BVPS
|
0.95 |
|
PB
|
2.26 |
|
EPS
|
-1.19 |
|
FCF
|
$-5,589,824.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:02 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:52 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PCSA documents filed with the SEC.
PCSA Filings
Clear
